Q08499 (PDE4D_HUMAN) Homo sapiens (Human)

cAMP-specific 3',5'-cyclic phosphodiesterase 4D UniProtKBInterProSTRINGInteractive Modelling

809 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; Isoform 7; Isoform 8; Isoform 9; Isoform 10; Isoform 11; Isoform 12); 1 identical sequence: Homo sapiens: A0A140VJR0

Available Structures

87 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
crystal structure of PDE4D catalytic domain and zardaverine complexhomo-6-merZN;MG;ZAR;388-715
Assess
PDE4 complexed with inhibitorhomo-4-mer3KQ;ZN;MG;387-738
Assess
Crystal structure of PDE4D2 in complex with inhibitor LEO39652homo-4-merQDT; 28×EDO;DMS;MG;ZN;381-714
Assess
Crystal structure of PDE4D in complex with L-869298homo-4-merZN;MG;M98;381-714
Assess
Crystal structure of PDE4D2 in complex with (R,S)-rolipramhomo-4-merZN;ROL;381-714
Assess
Crystal structure of PDE4D2 in complex with inhibitor L-869299homo-4-merZN;MG;M99;381-714
Assess
Structure of PDE4D2-IBMXhomo-4-merZN;MG;IBM;381-714
Assess
Three dimensional structures of PDE4D in complex with roliprams and implication on inhibitor select…homo-4-merZN;ROL;381-714
Assess
The Crystal Structure of AMP-Bound PDE4 Suggests a Mechanism for Phosphodiesterase Catalysishomo-4-merZN;AMP;381-714
Assess
Crystal structure of the PDE4D catalytic domain in complex with GEBR-42ahomo-2-merZN;MG; 28×EDO;T3K;382-714
Assess
Crystal structure of the PDE4D catalytic domain in complex with GEBR-41bhomo-2-merS8Q;ZN;MG; 14×EDO;382-714
Assess
Crystal structure of the PDE4D catalytic domain in complex with GEBR-18ahomo-2-merZN;MG;D0E;383-714
Assess
Crystal structure of the PDE4D catalytic domain in complex with GEBR-4ahomo-2-merZN;MG;CZT;386-714
Assess
Crystal structure of the PDE4D catalytic domain in complex with GEBR-7bhomo-2-merMG;ZN;CV8;GOL;386-714
Assess
Crystal structure of the PDE4D catalytic domain in complex with GEBR-18bhomo-2-merZN;MG;D0B;387-714
Assess
Crystal structure of PDE4D catalytic domain in complex with arctigeninhomo-2-merZN;MG;EQC; 26×EDO;388-714
Assess
Structure of the PDE4D-cAMP complexhomo-2-merZN;CMP;388-714
Assess
Crystal structure of PDE4D2 in complex with inhibitor NPVhomo-2-merNPV;ZN;MG;388-714
Assess
Crystal structure of PDE4D catalytic domain in complex with Apremilasthomo-2-merMG;ZN; 11×EDO;A9L;388-714
Assess
The structure of the catalytic domain of human PDE4d with 4-(3-Butoxy-4-methoxyphenyl)methyl-2-imid…homo-2-merZN;0MO;MG;388-714
Assess
Crystal structure of PDE4D catalytic domain in complex with compound 36homo-2-merZN;MG;FTX; 12×EDO;388-713
Assess
Crystal structure of PDE4D complexed with a novel inhibitorhomo-2-merMG;ZN;AH6; 11×EDO;389-713
Assess
Crystal structure of PDE4D complexed with a novel inhibitorhomo-2-merZN;MG;AH9; 11×EDO;389-713
Assess
Crystal structure of PDE4D complexed with a novel inhibitorhomo-2-merZN;MG;AJX; 14×EDO;389-713
Assess
Crystal structure of PDE4D complexed with a novel inhibitorhomo-2-merZN;MG;AH3; 13×EDO;389-713
Assess
Crystal structure of PDE4D complexed with a novel inhibitorhomo-2-merAKO;MG;ZN;EDO;389-713
Assess
PDE4D complexed with inhibitorhomo-2-mer3GJ;ZN;389-713
Assess
Crystal structure of PDE4D complexed with a novel inhibitorhomo-2-merZN;MG; 10×EDO;AK0;390-713
Assess
Crystal structure of PDE4D complexed with a novel inhibitorhomo-2-merZN;MG;AH9; 15×EDO;390-713
Assess
Crystal structure of PDE4D complexed with a novel inhibitorhomo-2-merZN;MG;AJL; 12×EDO;390-713
Assess
Crystal structure of PDE4D complexed with a novel inhibitorhomo-2-merZN;MG;AKU;EDO;390-713
Assess
Crystal structure of the PDE4D catalytic domain in complex with GEBR-26ghomo-2-merZN;MG;D08;EDO;DMS;392-715
Assess
PDE4D crystal structure in complex with small molecule inhibitorhomo-2-merZN;MG;6Q2; 32×EDO;390-713
Assess
Crystal structure of PDE4D complexed with a novel inhibitorhomo-2-merZN;MG;AKU;EDO;390-713
Assess
Crystal structure of human phosphodiesterase 4d (PDE4d) with papaverine.homo-2-merZN;MG;EV1;388-711
Assess
Crystal structure of the PDE4D catalytic domain in complex with GEBR-54homo-2-merCZK;MG;ZN;EDO;392-714
Assess
Crystal structure of the PDE4D catalytic domain in complex with GEBR-20bhomo-2-merZN;MG;CZQ;392-714
Assess
Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with T-48monomerZN;MG;KRD;326-718
Assess
Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with BPN14770monomerZN;MG;KR7;BTB;SO4;EDO;326-718
Assess
Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with T-49monomerZN;MG;KR4;326-718
Assess
Crystal structure of human phosphodiesterase 4D with bound allosteric modulatormonomer15X;ZN;MG;EPE;326-714
Assess
Crystal structure of human phosphodiesterase 4d with regulatory domain and d155871monomerZN;MG;CA;D71;327-714
Assess
Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with BPN5004monomerZN;MG;E31;CL;390-734
Assess
Crystal structure of human phosphodiesterase 4d with d155988/pmnpqmonomerZN;MG;SO4;988;EDO;380-714
Assess
Crystal structure of PDE4D catalytic domain complexed with Selaginpulvilins KmonomerJ20;ZN;MG;381-714
Assess
Crystal structure of human phosphodiesterase 4d with d155871monomerZN;MG;SO4;D71;EOH;384-714
Assess
Crystal structure of the catalytic domain of PDE4D2 with (S)-N-(3-{1-[1-(3-Cyclopropylmethoxy-4-dif…monomerIHM;ZN;384-714
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-048monomerZN;MG; 13×EDO;EPE;E6Z;383-713
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-226monomerZN;MG; 21×EDO;PEG;D5T;384-713
Assess
Crystal structure of human phosphodiesterase 4d with roliprammonomerZN;MG;SO4;ROL;EDO;384-713
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-356monomerZN;MG; 15×EDO;PEG;D62;EPE;384-713
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-001monomerZN;MG;EDO;DTT;6M5;384-713
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-007monomerZN;MG; 20×EDO;PEG;EPE;E8H;385-713
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1439monomerZN;MG; 19×EDO;PEG;D68;EPE;NI;385-713
Assess
Crystal structure of the catalytic domain of PDE4D2 with compound 10DmonomerZN; 16×EDO;DMS;PEG;PO4;JN4;385-713
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-637monomerZN;MG; 10×EDO;E3Q;385-713
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-053monomerZN;MG; 12×EDO;PEG;DTT;385-713
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-425monomerZN;MG;EDO;E6E;EPE;385-713
Assess
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH A TETRAFLUORANLINE COMPOUNDmonomerZN;MG;SO4;EOH;7DJ;386-714
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-417monomerZN;MG;EDO;EPE;4I7;385-713
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-3098monomerZN;MG;EDO;E6N;EPE;385-713
Assess
Crystal structure of human phosphodiesterase 4d with roflumilastmonomerZN;MG;SO4;ROF;EDO;385-713
Assess
Crystal structure of the catalytic domain of PDE4D2 with compound 2monomer2SR;EDO;PEG;ZN;DMS;385-712
Assess
Crystal structure of the catalytic domain of PDE4D2 complexed with compound 10dmonomerZN;J25;EDO;DMS;385-712
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1335monomer15×EDO;PEG;ZN;FFZ;MG;EPE;385-711
Assess
Crystal structure of the apo form of the catalytic domain of PDE4D2monomer17×EDO;PEG;ZN;PO4;385-711
Assess
Crystal structure of PDE4D catalytic domain complexed with compound 1monomerZN;MG;MKU;387-713
Assess
Crystal structure of the catalytic domain of PDE4D2 with compound 12cmonomerZN;EDO;JN8;386-712
Assess
Crystal structure of the catalytic domain of PDE4D2 with compound 10omonomer13×EDO;ZN;PEG;JN7;386-712
Assess
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 3,5-dimethyl-1-(3-nitro-phenyl)-1H-p…monomerZN;MG;7DE; 18×EDO;388-713
Assess
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 3,5-dimethyl-1H-pyrazole-4-carboxyli…monomerZN;MG;DEE; 11×EDO;388-713
Assess
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With CilomilastmonomerZN;MG;CIO;EDO;388-713
Assess
Crystal structure of PDE4D2 in complex with inhibitor (S_Zl-n-91)monomerAKJ;ZN;MG;388-713
Assess
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 3,5-dimethyl-1-phenyl-1H-pyrazole-4-…monomerZN;MG;3DE; 10×EDO;388-713
Assess
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 1-(4-methoxy-phenyl)-3,5-dimethyl-1H…monomerZN;MG;4DE; 12×EDO;388-713
Assess
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With PiclamilastmonomerZN;MG;PIL;B3P; 20×EDO;388-713
Assess
Crystal structure of the PDE4D2 catalytic domain in complex with inhibitor (R)-Zl-n-91monomerR91;ZN;MG;388-713
Assess
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With RoflumilastmonomerZN;MG; 12×EDO;ROF;388-713
Assess
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 1-(4-amino-phenyl)-3,5-dimethyl-1H-p…monomerZN;MG;5DE;EDO;388-713
Assess
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With AMPmonomerZN;MG;AMP; 14×EDO;B3P;389-713
Assess
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1086monomer11×EDO;D5Z;MG;ZN;EPE;390-714
Assess
Crystal structure of the PDE4D catalytic domain in complex with ostholemonomerZN;A0O;390-714
Assess
PDE4 crystal structure in complex with small molecule inhibitormonomer6PT;ZN;MG;389-713
Assess
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With ZardaverinemonomerZN;MG;ZAR;390-713
Assess
Catalytic Domain Of Human Phosphodiesterase 4D In Complex With RoliprammonomerZN;MG;ROL;EDO;390-713
Assess
Crystal structure of PDE4D catalytic domain complexed with compound 4emonomerM36;ZN;MG;390-712
Assess
The structure of the RACK1 interaction sites located within the unique N-terminal region of the cAM…monomer250-280
Assess

2 Homology models

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
homo-2-merZN;0.803g45.1.A305-714
86.71
Assess
homo-2-merZN;0.774wzi.1.A223-713
79.22
Assess

21 Homology models built on isoform sequence

IsoformOligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
Isoform 2homo-2-merZN;0.803g45.1.A169-578
86.71
Assess
Isoform 2homo-2-merZN;0.774wzi.1.A87-577
79.22
Assess
Isoform 3homo-2-merZN;0.803g45.1.A100-509
86.71
Assess
Isoform 3homo-2-merZN;0.774wzi.1.A18-508
78.76
Assess
Isoform 4homo-2-merZN;0.803g45.1.A80-489
86.71
Assess
Isoform 4homo-2-merZN;0.774wzi.1.A45-488
80.68
Assess
Isoform 5homo-2-merZN;0.813g45.1.A3-412
86.59
Assess
Isoform 5homo-2-merZN;0.804wzi.1.A1-411
80.60
Assess
Isoform 6homo-2-merZN;0.803g45.1.A241-650
86.71
Assess
Isoform 6homo-2-merZN;0.774wzi.1.A159-649
79.22
Assess
Isoform 6monomer0.601e9k.1.A12-49
100.00
Assess
Isoform 7monomer0.661e9k.1.A12-49
100.00
Assess
Isoform 8homo-2-merZN;0.803g45.1.A14-423
84.78
Assess
Isoform 8homo-2-merZN;0.804wzi.1.A16-422
80.43
Assess
Isoform 9homo-2-merZN;0.803g45.1.A183-592
86.71
Assess
Isoform 9homo-2-merZN;0.774wzi.1.A101-591
79.22
Assess
Isoform 10homo-2-merZN;0.803g45.1.A175-584
86.71
Assess
Isoform 10homo-2-merZN;0.774wzi.1.A93-583
79.22
Assess
Isoform 11homo-2-merZN;0.803g45.1.A244-653
86.71
Assess
Isoform 11homo-2-merZN;0.774wzi.1.A162-652
79.22
Assess
Isoform 12monomer0.651e9k.1.A12-49
100.00
Assess

Alignments